[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nuritas Ltd\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":127},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,58,94],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":35,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":57},"100633575","the-effects-of-peptistrong-and-whey-on-muscle-function-in-older-adults-100633575",false,"NCT07528469","The Effects of PeptiStrong and Whey on Muscle Function In Older Adults","The Effects of PeptiStrong and Low Dose Whey Protein Versus High Dose Whey Protein Alone on Muscle Function In Older Adults","Inclusion Criteria:\n\n* Men and women aged 60 to 85 years at the time of enrolment\n* Community-dwelling (living independently or with minimal assistance)\n* Able to walk independently (with or without a walking aid) and complete simple physical function tests (such as standing up from a chair and walking short distances)\n* Willing and able to attend two study visits at the research facility (baseline and end of study)\n* Willing and able to consume a protein drink containing whey protein (derived from milk) once daily for 30 days\n* Able to understand the study information and provide written informed consent\n\nExclusion Criteria:\n\n* Any known food allergy or intolerance to fava bean protein or milk protein\n* Diagnosed kidney disease or any medical condition where increased protein intake is contraindicated\n* Yes to any of the answers on the \"Older Adult Functional Assessment Screening Questionnaire\"\n* Individuals with implanted electronic devices\n* Current or recent (within the past 3 months) participation in another clinical research study involving a nutritional or exercise intervention\n* Conditions that significantly impair mobility or balance such that safe completion of the physical function tests is not possible",true,"ALL","60 Years","85 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","Examining the effects of PeptiStrong and protein on muscle function in older adults",[28,29,30,31,32,33,34],"Healthy Ageing","Protein Supplementation","Muscle Health","Muscle Function","Hand Grip Strength","Longevity","Peptides",[36,37,38,39,33,40,41,42,43,44],"Healthy Aging","Protein supplementation","Muscle function","Physical performance","Bioactive peptides","Hand grip strength","Short performance physical battery","Nuritas","Liverpool John Moore University","RECRUITING","2026-04-30",{"date":48,"type":49},"2026-05-06","ACTUAL",{"date":51,"type":49},"2026-04-06",{"date":53,"type":22},"2026-10-30",{"name":55,"class":56},"Nuritas Ltd","INDUSTRY",1,{"id":59,"slug":60,"hasResults":11,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":4,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":65,"targetDuration":4,"studyType":23,"phases":67,"briefSummary":68,"conditions":69,"keywords":75,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},"100617748","the-effects-of-medidrink-platinum-and-fava-bean-protein-hydrolysate-on-fitness-in-an-aged-population-100617748","NCT07322653","The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population","Prospective, Open-Label, Multicenter Study to Characterise the Effects of Co-administration of MediDrink Platinum+ Formula Containing Novel Protein Blend SPR-01 and Fava Bean Protein Hydrolysate on Fitness in an Aged Population","Inclusion Criteria:\n\n* 60 years or older\n* BMI ≤ 25 kg\u002Fm²\n* Malnourished (mini nutritional assessment MNA \\\u003C11\n* Sarcopenic: SARC-F score ≥ 4\n* Capable or oral feeding either alone or assisted\n* Ambulatory (WHO PS\u002FECOG 0-3)\n* Ability to complete questionnaires and self assess health status\n* Ability to provide consent\n\nExclusion Criteria:\n\n* Patient cannot eat orally\n* Acute Infection\n* Proven Intestinal obstruction\n* Co-morbidities requiring a special diet (diabetes, kidney disease etc.)\n* Liver dysfunction\n* Acute or chronic renal failure\n* Uncontrollable nausea or vomiting\n* Use of megestrol acetate or metabolic steroids\n* Dietary supplement use in the last 3 months\n* Known intolerance or allergy to the investigational products\n* Participation in any clinical trial within the last 3 months",{"count":66,"type":22},75,[25],"Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia",[70,71,29,72,73,74],"Sarcopenia in Elderly","Malnourished","Muscle Mass","Physical Function","Strength",[76,77,78,79,80,81,82,83,84],"Sarcopenia","Peptide Therapeutics","PeptiStrong","MediDrink Platinum","Malnourished Elderly","Physical functioning","MediDrink Platinum+","Clinical Nurtition","Nutritional status","2025-12-22",{"date":87,"type":49},"2026-01-07",{"date":89,"type":49},"2025-09-10",{"date":91,"type":22},"2027-01-02",{"name":55,"class":56},2,{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":4,"eligibilityCriteria":100,"healthyVolunteers":16,"sex":17,"minAge":101,"maxAge":102,"enrollmentInfo":103,"targetDuration":4,"studyType":23,"phases":105,"briefSummary":106,"conditions":107,"keywords":114,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":57},"100584862","effects-of-lentil-protein-hydrolysate-on-blood-pressure-control-vascular-function-and-exercise-performance-100584862","NCT06894875","Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","Examining the Safety and Tolerability of Lentil Protein Hydrolysate in Healthy Males and Females Whilst Exploring the Effects of a Dose Range on Blood Pressure Control and Vascular Function and Exercise Performance","Inclusion Criteria:\n\n* Willing to provide written and dated informed consent to participate in the study.\n* Willing and able to comply with the protocol.\n* Are not on any medication, or supplements which would impact the trial in the opinions of the investigator or Sponsor.\n* Male or female between 18 and 45 years of age (18.5 kg\u002Fm2 ≥ BMI \\\u003C 30 kg\u002Fm2).\n* Comply with ACSM guidelines for physical activity.\n* Have not participated in a clinical trial within the past month and agree to not participate in another clinical trial during the study period.\n* Agree to not significantly alter diet or exercise routine during the trial period.\n* Willing to wear a wearable device continuously for the duration of the study\n\nExclusion Criteria:\n\n* Subjects having a known allergy or hypersensitivity to any of the ingredients in the investigational products.\n* Subjects with a history of alcohol and\u002For other drug abuse in the past year.\n* Has performed strenuous exercise (rating of perceived exertion ≥ 13) ≤ 48 hours before laboratory visit (Borg, 1982).\n* Consuming \\>14 alcoholic drinks per week or \\> 2 drinks\u002Fday in the 48 hours preceding a clinic visit.\n* Active smokers, nicotine use or vaping\n* Subjects suffering from a sleep disorder and\u002For who have a known history of (or was being treated for) clinical depression, eating disorder(s) or any other psychiatric condition(s) that might put the subject at risk and\u002For confounded the results of the study.\n* Subjects with a history of being diagnosed with phenylketonuria or another disease affecting amino acid metabolism (i.e., maple syrup urine disease, etc.).\n* Subjects with an elevated resting heart rate (\\>100 bpm) or blood pressure (systolic BP \\>140 mmHg or diastolic BP \\>90 mmHg).\n* Pregnant or lactating women\n* Presentation of orthostatic hypotension during the screening and familiarisation study visit\n* Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion.","18 Years","45 Years",{"count":104,"type":22},48,[25],"Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance",[108,109,110,111,112,113],"Exercise","Blood Pressure","Vasodilation","Vascular Function in Healthy Volunteers","Exercise Performance","Safety and Tolerability in Healthy Volunteers",[115,116,117,118],"Exercise performance","Vascular function","blood pressure control","Lentil protein hydrolysate","2025-12-15",{"date":121,"type":49},"2025-12-16",{"date":123,"type":49},"2025-06-24",{"date":125,"type":22},"2026-03-30",{"name":55,"class":56},""]